PRINCETON, N.J., April 28, 2011 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced today that Valerie Palumbo has joined the Company as Senior Vice President, Corporate Quality Assurance.
"We are very pleased to have Valerie join us," said Thomas Newman, MD, President, PharmaNet Development Group. "Valerie brings deep experience in developing global programs that will enhance our quality processes and augment our existing compliance programs."
Ms. Palumbo has more than twenty years of experience in the development and implementation of quality assurance programs in the FDA-regulated drug and medical device industries. Her experience includes oversight of pre-clinical, clinical, and clinical supplies manufacturing activities. In addition, Ms. Palumbo has significant experience in the globalization of policies and procedures that drive company-wide compliance, and in the implementation and enhancement of computer system validation and 21 CFR Part 11 compliance processes.
PharmaNet Development Group, Inc., a recognized leader of global drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries, provides comprehensive capabilities in Phase I-IV clinical development, bioanalytical and bioequivalence services, regulatory, staffing, and therapeutic solutions. For the applied knowledge and intelligent solutions needed to accelerate drug development programs of all sizes around the world, PharmaNet works for you. For more information, please visit www.PharmaNet.com.
Contact: Anne-Marie Hess
Phone: (609) 951-6842
SOURCE PharmaNet Development Group, Inc.